Rhumbline Advisers »

Vor Biopharma shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 58k 18.41

More positions owned by Rhumbline Advisers

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Micron Technology (MU)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Visa (V)

View all positions for Rhumbline Advisers

Top funds holding Vor Biopharma

TCG Crossover Management
FMR
Fcpm Iii Services B.v.
BlackRock
VR Adviser
Frazier Life Sciences Management
RA Capital Management
Vanguard Capital Management
Caligan Partners
Paradigm Biocapital Advisors
Dr. Jeffrey R. Jay, M.D.
State Street Corporation
Geode Capital Management
Nantahala Capital Management
ADAR1 Capital Management

View all funds holding Vor Biopharma